Cargando…

Impact of Aurora Kinase A Polymorphism and Epithelial Growth Factor Receptor Mutations on the Clinicopathological Characteristics of Lung Adenocarcinoma

Lung adenocarcinoma (LADC) is the most common subtype of lung cancer worldwide and the epidermal growth factor receptor (EGFR) has a great influence on its clinical course, mainly due to the influence of different phenotypes. The Aurora kinase A (AURKA) would influence the progression of several sol...

Descripción completa

Detalles Bibliográficos
Autores principales:	Yang, Po-Jen, Hsieh, Ming-Ju, Lee, Chun-I, Yen, Chi-Hua, Wang, Hsiang-Ling, Chiang, Whei-Ling, Liu, Tu-Chen, Tsao, Thomas Chang-Yao, Lee, Chia-Yi, Yang, Shun-Fa
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	MDPI 2020
Materias:	Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7579084/ https://www.ncbi.nlm.nih.gov/pubmed/33050100 http://dx.doi.org/10.3390/ijerph17197350

Ejemplares similares

The impact of Aurora kinase A genetic polymorphisms on cervical cancer progression and clinicopathologic characteristics
por: Wu, Pei-Ju, et al.
Publicado: (2021)

The Impact of HMGB1 Polymorphisms on Prostate Cancer Progression and Clinicopathological Characteristics
por: Chou, Ying-Erh, et al.
Publicado: (2020)

Correlation of E-cadherin gene polymorphisms and epidermal growth factor receptor mutation in lung adenocarcinoma
por: Huang, Chun-Yao, et al.
Publicado: (2018)

Association of endothelial nitric oxide synthase (eNOS) polymorphisms with EGFR-mutated lung adenocarcinoma in Taiwan
por: Huang, Chun-Yao, et al.
Publicado: (2018)

Associations of TIMP-3 Genetic Polymorphisms with EGFR Statuses and Cancer Clinicopathologic Development in Lung Adenocarcinoma Patients
por: Chang, Jer-Hwa, et al.
Publicado: (2020)

The Clinical Significance of the Insulin-Like Growth Factor-1 Receptor Polymorphism in Non-Small-Cell Lung Cancer with Epidermal Growth Factor Receptor Mutation
por: Liu, Tu-Chen, et al.
Publicado: (2016)

Fibroblast Growth Factor Receptor 4 Polymorphism Is Associated with Liver Cirrhosis in Hepatocarcinoma
por: Sheu, Ming-Jen, et al.
Publicado: (2015)

The Relationship between Long Noncoding RNA H19 Polymorphism and the Epidermal Growth Factor Receptor Phenotypes on the Clinicopathological Characteristics of Lung Adenocarcinoma
por: Wang, Yao-Chen, et al.
Publicado: (2021)

CD44 Gene Polymorphisms on Hepatocellular Carcinoma Susceptibility and Clinicopathologic Features
por: Chou, Ying-Erh, et al.
Publicado: (2014)

Association of Carbonic Anhydrase 9 Polymorphism and the Epithelial Growth Factor Receptor Mutations in Lung Adenocarcinoma Patients
por: Yu, Ya-Yen, et al.
Publicado: (2020)

Genetic Associations of Visfatin Polymorphisms with EGFR Status and Clinicopathologic Characteristics in Lung Adenocarcinoma
por: Chang, Sunny Li-Yun, et al.
Publicado: (2022)

Impact of LncRNA GAS5 Genetic Variants and the Epidermal Growth Factor Receptor Phenotypes on the Clinicopathological Characteristics of Lung Adenocarcinoma Patients
por: Hsieh, Ming-Hong, et al.
Publicado: (2022)

Effect of WW Domain-Containing Oxidoreductase Gene Polymorphism on Clinicopathological Characteristics of Patients with EGFR Mutant Lung Adenocarcinoma in Taiwan
por: Li, Ju-Pi, et al.
Publicado: (2021)

Association between survivin genetic polymorphisms and epidermal growth factor receptor mutation in non-small-cell lung cancer
por: Liu, Tu-Chen, et al.
Publicado: (2016)

CD44 Gene Polymorphisms as a Risk Factor for Susceptibility and Their Effect on the Clinicopathological Characteristics of Lung Adenocarcinoma in Male Patients
por: Li, Ju-Pi, et al.
Publicado: (2020)

Effects of ADAMTS14 genetic polymorphism and cigarette smoking on the clinicopathologic development of hepatocellular carcinoma
por: Sheu, Ming-Jen, et al.
Publicado: (2017)

Aurora Kinase A Is a Prognostic Marker in Colorectal Adenocarcinoma
por: Koh, Hyun Min, et al.
Publicado: (2017)

Significance of Aurora B overexpression in hepatocellular carcinoma. Aurora B Overexpression in HCC
por: Lin, Zhong-Zhe, et al.
Publicado: (2010)

Association of lncRNA CCAT2 and CASC8 Gene Polymorphisms with Hepatocellular Carcinoma
por: Wu, Edie-Rosmin, et al.
Publicado: (2019)

Relationship of Genetic Polymorphisms of the Chemokine, CCL5, and Its Receptor, CCR5, with Coronary Artery Disease in Taiwan
por: Ting, Ke-Hsin, et al.
Publicado: (2015)

Variations in the AURKA Gene: Biomarkers for the Development and Progression of Hepatocellular Carcinoma
por: Wang, Bin, et al.
Publicado: (2018)

Unfolded Protein Response Is Activated by Aurora Kinase A in Esophageal Adenocarcinoma
por: Lu, Heng, et al.
Publicado: (2022)

Involvement of FGFR4 Gene Variants on the Clinicopathological Severity in Urothelial Cell Carcinoma
por: Tsay, Ming-Dow, et al.
Publicado: (2019)

Aurora Kinases and Potential Medical Applications of Aurora Kinase Inhibitors: A Review
por: Gavriilidis, Paschalis, et al.
Publicado: (2015)

Impact of tissue inhibitor of metalloproteinases-3 genetic variants on clinicopathological characteristics of urothelial cell carcinoma
por: Weng, Wei-Chun, et al.
Publicado: (2023)

Identification of aurora kinase A as an unfavorable prognostic factor and potential treatment target for metastatic gastrointestinal stromal tumors
por: Yeh, Chun-Nan, et al.
Publicado: (2014)

Aurora Kinase A Regulation by Cysteine Oxidative Modification
por: Lee, In-Gyun, et al.
Publicado: (2023)

The impact of receptor of advanced glycation end‐products polymorphisms on prostate cancer progression and clinicopathological characteristics
por: Chou, Ying‐Erh, et al.
Publicado: (2021)

Specific distribution of overexpressed aurora B kinase in interphase normal epithelial cells
por: Abdullah, Ash-shafie, et al.
Publicado: (2005)

Aurora kinases in ovarian cancer
por: Pérez-Fidalgo, J Alejandro, et al.
Publicado: (2020)

Aurora at the pole and equator: overlapping functions of Aurora kinases in the mitotic spindle
por: Hochegger, Helfrid, et al.
Publicado: (2013)

Impact of pentraxin 3 genetic variants on uterine cervical cancer clinicopathologic characteristics
por: Sun, Yi-Hung, et al.
Publicado: (2021)

Analysis of MUC6 Genetic Variants on the Clinicopathologic Characteristics of Patients with Hepatocellular Carcinoma
por: Lee, Hsiang-Lin, et al.
Publicado: (2022)

Aurora kinases: novel therapy targets in cancers
por: Tang, Anqun, et al.
Publicado: (2017)

Integrative network analysis of early-stage lung adenocarcinoma identifies aurora kinase inhibition as interceptor of invasion and progression
por: Yoo, Seungyeul, et al.
Publicado: (2022)

FGFR4 Gene Polymorphism Reduces the Risk of Distant Metastasis in Lung Adenocarcinoma in Taiwan
por: Li, Ju-Pi, et al.
Publicado: (2020)

Aurora kinases in childhood acute leukemia: the promise of aurora B as therapeutic target
por: Hartsink-Segers, S A, et al.
Publicado: (2013)

CD44 Gene Polymorphisms and Environmental Factors on Oral Cancer Susceptibility in Taiwan
por: Chou, Ying-Erh, et al.
Publicado: (2014)

CEP55 promotes cilia disassembly through stabilizing Aurora A kinase
por: Zhang, Yu-Cheng, et al.
Publicado: (2021)

Plasma levels of the tissue inhibitor matrix metalloproteinase-3 as a potential biomarker in oral cancer progression
por: Su, Chun-Wen, et al.
Publicado: (2017)

Cannot write session to /tmp/vufind_sessions/sess_8lof0tgl4b786m621nne22n3pl